States to receive 48 lakh vaccine doses in next three days: Centre
SECTIONS
Last Updated: May 24, 2021, 02:50 PM IST
Share
Synopsis
As part of the nationwide vaccination drive, the Centre been supporting the states and UTs by providing them COVID vaccines free of cost. In addition, it has also been facilitating direct procurement of vaccines by the states and UTs.
According to the Centre, more than 1.80 crore COVID vaccine doses (1,80,43,015) are still available with the states and UTs to be administered.
More than 1.80 crore COVID-19 vaccine doses are still available with the states and UTs and they will receive over 48 lakh doses in the next three days, the Union Health Ministry said on Monday. The Centre has so far provided, both through the free of cost category and through direct state procurement category, more than 21.80 crore vaccine doses to states and UTs.
India News: India is trying to save scarce Covid-19 vaccines by delaying shots for those who have recovered from the disease, the head of a government panel said,
++ Coronavirus hoy: la tercera ola pierde fuerza en Alemania ++ | Coronavirus | DW dw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dw.com Daily Mail and Mail on Sunday newspapers.
++ Coronavirus hoy: Continúa el peor repunte en Taiwán ++ | Coronavirus | DW dw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dw.com Daily Mail and Mail on Sunday newspapers.
The 2-billion Vaccine Question: How realistic are estimates and what s the current status?
SECTIONS
Share
Synopsis
The Centre’s plan for 2 billion doses of Covid-19 vaccines by year-end depends on a massive ramp-up of production as well as flawless trials, approval and manufacturing of five new vaccines. How realistic are the estimates? In what stages are the new vaccines now?
AP
Amid a shortage of Covid-19 vaccines, which has seen many states suspend inoculation sessions, the Centre on May 13 announced that 2 billion doses would be available by the end of the year. This would be a significant leap from the approximately 80 million doses a month currently available.